In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
ORIGINAL PAPER doi: 10.5455/medarh.2015.69.212-217
Med Arh. 2015 Aug; 69(4): 212-217 Received: May 15th 2015 | Accepted: July 05th 2015
2015 Zahra Ghobadian, Mohammad Reza Hafezi Ahmadi, Leila
Rezazadeh, Ehsan Hosseini, Taleb Kokhazadeh, Samiramis Ghavam
This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted
non-commercial use, distribution, and reproduction in any medium,
provided the original work is properly cited.
In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
Zahra Ghobadian1, Mohammad Reza Hafezi Ahmadi2, Leila Rezazadeh3, Ehsan Hosseini4, Taleb Kokhazadeh5, Samiramis Ghavam6*
1Faculty of Medicine,Ilam University of Medical Science,Ilam, Iran
2Departement of Pathobiology, Faculty of Medicine, Ilam University of Medical Science,Ilam, Iran
3Tabriz University of Medical Sciences,Faculty of Nutrition, Tabriz ,Iran
4Departement of Physiology, Faculty of Paraveterinary Ilam University,Ilam,Iran
5MSC in Nursing,Department of Nursing,Nursing and Midwifery Faculty, Ilam University of Medical Science,Ilam,Iran
6Departement of Cardiology, Ilam University of Medical Science,Ilam, Iran
Corresponding author: Dr. Samiramis Ghavam, Department of Cardiology, Ilam University of Medical Science,Ilam, Iran, E-mail: [email protected],Tel:+989127186169
ABSTRACT
Aim: In the present study, we aimed the eects of the hydroalcoholic extract of Achillea millefolium (HEAML) on human skin broblast cells (HSF-PI-16) proliferation, stimulation and growth properties. Methods: Initially, using HSF-PI-16 monolayer culture, we created one line scratch method as an in vitro wound closure and after 3 days monitored via an inverted microscopy. Results: HEAML selectively inhibited proliferation of HSF-PI-16 cells at higher concentration (>20.0 mg/mL), and stimulated at lower concentrations (<20.0 mg/mL).
Following, HSF-PI-16 media treatments up to 72 h, HEAML demonstrated signicantly elevated proliferation rates (p<0.05) and stimulation in a scratch wound assay (p<0.04). Furthermore, the morphological analysis of HSF-PI-16 cells at culture media were detected the gures of round to spindle, non-adherent, immature and mature cells. Conclusion: These results clearly demonstrate the absence of any toxic eect of HEAML on human skin broblasts. To the best of our knowledge, this is the rst report elucidating potential mechanisms of action of HEAML on broblasts proliferation, and stimulation, oering a greater insight and a better understanding of its eect in future studies.
Key words: Fibroblasts, Proliferation, Achillea millefolium, Skin, Culture.
1. INTRODUCTION
Nowadays, medicinal plants are widely utilized around the world as an alternative to pharmaceutical drugs. Although herbal products are considered to have fewer adverse eects compared with synthetic drugs, they are not completely free from side eects or toxicity (1). Recent phytochemical, pharmacological and clinical studies on various species have conrmed their ethno-medicinal properties. Achillea millefolium L. (Asteraceae) is widely used in Europe as a herbal remedy for the treatment of spasms, such as digestive complaints, as an emmenagogue, and for irregular menses (2). Several A. millefolium constituents including monoterpenes, sesquiterpenes, avonoids and caeoylquinic acid derivatives have been reported (3). Each class of phytoconstituents can at least in part account for specic medicinal properties of A. millefolium. Leaves and owers from A.millefolium have
been used for centuries for anti-inammatory actions, such as rheumatism, skin inammation and allergic rhinitis, wound healing and amelioration of diaphoresis and high blood pressure (4, 5, 6). Plant cell and tissue culture is a useful technology for producing plant specic bioactive compounds, and many hairy root cultures of it, which present genetic and biochemical stabilities similar to those of the mother plant, are established for more stable and efficient production of their active constituents (7).
Fibroblasts play a potential function in proliferation and migration in response to chemotactic, mitogenic and modulatory cytokines, and also autocrine and paracrine interactions (8, 9), and these cells have many applications in tissue engineering, genetics and aging research, diagnosis of peroxisomal disorders, cell nuclear transfer, and cell reprogramming (8, 9, 10). Following severe damage, broblasts inltrate the wound, secrete growth factors and
212 Med Arh. 2015 Aug; 69(4): 212-217
In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
cytokines, and deposit brotic extracellular matrix factors such as collagen I and bronectin (11). Fibroproliferative is a term used to describe myobroblast-rich tissues (12, 13, 14, 15). Proliferation of myobroblasts and myobro-blast precursors is important in broproliferative tissues, therefore understanding myobroblast proliferation and dierentiation is important in normal tissue remodeling and in broproliferative pathologies, such as Dupuytrens contracture (12), hypertrophic scars (16), myocardial infarction brosis (17), and pulmonary brosis (18), among others. The aim of study was to evaluate scratch wound assay on proliferation and cell migration of HSF-PI-16 cell number in RPMI + %10 FBS culture media after 24,28,and 72h at control and HEAML groups
2. MATERIALS AND METHOD
Aerial parts from Achillea millefolium L. were collected was collected in May 2014, from populations growing in Ilam province, Iran. The plant was identied in Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran. A voucher specimen was deposited in the herbarium of the above mentioned college.
Aerial parts (leaves, stalks and stems) of A. millefolium L. were air-dried in an oven at 35 to 45 C for 5 days. A. millefolium leaves were used in this study since these parts are utilized in traditional medicine. The aforementioned parts were ground to a ne powder. One gram of powder was extracted using 10 mL of ethanol/distilled water solution (alcohol/water = 8:2, v/v), with centrifugation at 3000 r/min for 15 minutes, and then the supernatant was collected. This process was repeated three times. Solvents were then removed by evaporation (19, 20). The dry plant was cut and pulverized. Three concentrations of hydroalcoholic extracts (AEAM; 2.5%, 5% and 10%) were prepared using the powdered plant material. For this, 100 g of powder was placed in 500 mL of distilled boiling water and kept at room temperature for 15 min. The infusions were freshly prepared just prior to administration at dosages of 0, 1000 or 2000 g/kg of AEAM. The extraction, fractionation and chemical characterization of the hydroalcoholic (HEAM) and dichloromethane subfractions (DCM-2) were performed as previously described (21).
Normal human skin broblasts were obtained from Science Cell Research Laboratories (Carlsbad, CA, USA) and were cultured in Dulbeccos modied Eagles medium (DME, Invitrogen Life Technologies, Burlington, ON, Canada) supplemented with fetal bovine serum (FBS) to a nal concentration of 10% (Gibco, Burlington, ON, Canada). The medium was changed three times a week. When the cultures reached 90% conuence, the cells were detached from the asks with a 0.05% trypsin-0.1% ethylene diamin tetra acetic acid (EDTA) solution, washed twice, and resuspended in FBS-supplemented DME medium. In each experiment, the broblasts were used between passages 4 and 5.
Human skin broblast (HSF-PI-16) were seeded uniformly (5.0104 cells/well) into 6-well macroplates (with each well containing a single cover-slip) at a RPMI + %10
FBS environment , after which time a scratch (wound) was created on each conuent monolayer using a 1mL sterile
pipette tip (PipetTipFinder, A division of Lab Procurement Services, LLC, Knoxville, TN, USA) perpendicular to the bottom of the dish, and then the plates incubated for a further 24 hr at 37C/5% CO2and grown for 24 hr with conditioned media being replenished every ~6 h. A wound scratch was made across the centre of each conuent cell culture using a sterile 1mL pipette tip and any non-adherent cells were washed o with 1 PBS. Conditioned media was then reapplied to the cells according to the previous treatment regimen and the plates incubated for a further 24 hr at 37C/5% CO2. Cellular xation was then achieved using 4% formaldehyde/PBS (Sigma-Aldrich, UK) applied for 30 min at RT, followed by permeabilization with PBS/0.1% Triton X-100 solution (Sigma-Aldrich, UK). The cells were then treated with 1:1000 diluted IC50 extract, then at next step one concentration of IC50 hydroalcoholic extract was added than the previous plates. The broblast cells at plates were then incubated at 37C for 12 hr with the conditioned medium. To record scratch wound closure, images were captured at 16, 20,38,44,64,70 and 88 hr time points in the same position using an Olympus IX71 microscope (Olympus, Southborough, MA, USA).Each well was photographed six times using objective inverted microscopy (Olympus, UK) and the number of cells that migrated into the scratched area counted (using a standardized scratch area for each image) as described previously (22).
Kinetic analysis of the migration process of HSF was measured using time-lapse microscopy. Cells were seeded in 2 compartments separated by a silicon insert (Ibidi devices). At subconuence, inserts were removed, cells were rinsed twice with PBS to remove non-adherent cells, and the culture medium was replaced by fresh medium containing or hydroalcoholic extract of Achillea millefolium leaves (HEAML) (0.19, 0.39, 0.78, 1.56, 3.12, 6.25, a, 12.5 ,and 25 mg/mL) and supplemented with 0.1% SVF. Cell migration was followed using an inverted time-lapse microscope equipped with an environmental chamber at 37C under 5% CO2. The microscope was controlled by
Metamorph software. Images were taken every 30 min and recorded with a charged-coupled camera for 48 h. Cell migration was quantied using Image J software.
All data is presented as mean +/ standard error of the mean (SEM) from repeated experiments. Statistical analysis was performed by using Students t-test, p<0.05 was considered statistically signicant.
3. RESULTS
3.1. HEAML produced no side eect on the human skin broblasts
We expanded human skin broblasts in culture and, as described above, transfected the cells with HSF-PI-16 levels (Figures 1 and 2). Similar to mesenchymal cells, over 30 % of the transfected broblasts expressed IC50, and also, we assumed that these HEAML might contribute to the transformation of the mesenchymal HSF-PI-16 cells into mentioned plates, and after determining the optimal dose and schedule, we added mentioned concentrations of HEAML at 24, 48 and 72h of culture and harvested the cells for analysis at days 1, 2 and 3. Under these conditions, over 20 and /or 30% of the cells expressed IC50 at high
Med Arh. 2015 Aug; 69(4): 212-217
213
In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
Time Control 0/19 0/39 0/78 1/56 3/12 6/25 12/5 25
24h
0/338 0/001 0 -0/001 0/002 0/008 0/011 0/073 0/181
0/387 0/002 0/003 0/003 0/008 0/011 0/022 0/155 0/278
0/37 0/002 -0/002 -0/002 0/002 0/008 0/017 0/136 0/247
48h
0/304 0/007 0/004 0/005 0/006 0/016 0/021 0/016 0/351
0/309 0/004 0/004 0/004 0/011 0/025 0/03 0/208 0/401
0/312 0/002 0/002 0 0/004 0/014 0/023 0/117 0/311
0/324 0/007 0/003 0/004 0/002 0/008 0/006 0/005 0/152
0/357 0/005 0/003 0/004 0/004 0/006 0/006 0/006 0/233
0/22 0/007 0/003 0/005 0/007 0/008 0/015 0/012 0/306
Table1. Scratch wound assay was performed on proliferation and cell migration of HSF-PI-16 cell number in RPMI + %10 FBS culture media a er 24,28,and 72h at control and HEAML groups
72h
72h
time, as compared with control group when the cells were exposed to HSF-PI-16 (Figures 3, 4 and 5). Th e HSF-PI-16 cells also expressed dierent levels of time and dose. HSFPI-16 cells treated with HEAML became round to spindle and small, as conrmed by morphological and side- and forward-scattered culture analysis (Figures 1 and 2). Th e cells became non-adherent, and acquired cell surface markers and morphological features typical of immature and mature cells of all hematopoietic lineages. Th ese data are supported by the cell viability analysis. As shown in Figures 3, 4 and 5, dierence in cell density was observed between the HEAML -exposed and non-exposed bro-blast cultures. Th ere was also dierence when cells were exposed for 24, 48 and 72 h to either low or high mg/ml. It is, however, interesting to note that the exposure to HEAML for 3days produced a signicantly (p<0.05) higher cell count compared to the non-exposed control culture. Th ese results clearly demonstrate the absence of any toxic eect of HEAML on human skin broblasts.
3.2. HEAML promoted cell migration of HSF-PI-16 and scratch closure and morphological observation
In this study, broblast migration capacity in the presence or absence of HEAML was investigated using an in vitro wound scratch assay. Migration of HSF-PI-16 into
24 hours 72 hours
Figure 2. Fibroblasts in cultures. 5.0104 broblasts, were cultured in 6-well macroplates (with each well containing a single cover-slip) for 72 hours, and then HEAML, were seeded into the wells with HSF-PI-16 cells. On day 2, broblasts tended to cover the entire bottom of the well and on day 3, the overgrowing broblasts resulted in some cells grew on others. In the presence of IC50, wound closure was nearly complete at this time (72h). Original magnication 400. b) There was a signicant increase in the extent of wound closure in HSF-PI-16 scratch assays in HEAML compared with the control medium at 27h. Data shown are meansSEM, *p<0.05. Representative inverted microscope images of HSF-PI-16 scratch assays immediately a er the scratches had been made and then a er 24h in the presence of extract free IC50 versus test medium.
Scratch-wound assay
assay
Fig1: Microscopic observation of HSF-PI-16 fibroblasts. A representative image is shown of primary cultured HSF-PI-16 fibroblasts (400 magnification). The cells appeared elongated or flattened, and some were triangular.HSF-PI-16 fibroblasts closed scratch assay wounds more rapidly in control and treat groups. a) The extent of wound closure in scratch assays of HSF-PI-16
fibroblasts at 72 h in cultures with 10% FBS. Data shown are the means ( SEM), *p < 0.05. b) FBS in serum supplemented cultures; the HSF-PI-16 fibroblasts migrated into the wound area more rapidly in cultures. Representative images are shown of the progression of wound closure at 24 and 72 h, at which time the HSF-PI-16 fibroblasts can be seen to fill the wound area almost to the exclusion of HEAML. Original magnification 100 and 400.
Figure 1. Microscopic observation of HSF-PI-16 broblasts. A representative image is shown of primary cultured HSF-PI-16 broblasts (400 magnication). The cells appeared elongated or attened, and some were triangular.HSF-PI-16 broblasts closed scratch assay wounds more rapidly in control and treat groups. a) The extent of wound closure in scratch assays of HSF-PI-16 broblasts at 72h in cultures with 10% FBS. Data shown are the means (SEM), *p<0.05. b) FBS in serum supplemented cultures; the HSF-PI-16 broblasts migrated into the wound area more rapidly in cultures. Representative images are shown of the progression of wound closure at 24 and 72h, at which time the HSF-PI-16 broblasts can be seen to ll the wound area almost to the exclusion of HEAML. Original magnication 100 and 400.
Fig2. Fibroblasts in cultures. 5.010 fibroblasts, were cultured in 6-well macroplates (with each well
containing a single cover-slip) for 72 hours, and then HEAML, were seeded into the wells with HSF
PI-16 cells. On day 2, fibroblasts tended to cover the entire bottom of the well and on day 3, the
overgrowing fibroblasts resulted in some cells grew on others. In the presence of IC50, wound closure
was nearly complete at this time (72h). Original magnification 400. b) There was a significant
increase in the extent of wound closure in HSF-PI-16 scratch assays in HEAML compared with the
control medium at 27 h. Data shown are means SEM, *p < 0.05. Representative inverted
microscope images of HSF-PI-16 scratch assays immediately after the scratches had been made and
then after 24 h in the presence of extract free IC50 versus test medium.
a scratch wound inicted across conuent cultures (following 81 of media treatments) was signicantly elevated in HEAML media-treated broblasts compared to non-HEAML control media (p<0.05). Fibroblasts revealed cultures were conuent prior to scratching and HSF-PI-16 cells of HEAML groups orientated in parallel monolayers in contrast to control cells, which formed whirl-like aggregates in a similar manner to the whirl-like nodular structures demonstrated in post-conuent cultures. Th erefore, HSF-PI-16 cells treated with HEAML media elicited strong migration into the scratch wound. Furthermore, HSF-PI-16 media treatments of HEAML elicited statistically signicant (p<0.05) increased proliferation after 24, 48 and 72hrs compared to the HSF-PI-16 media controls (Figures 3, 4 and 5). After 72 h signicant increases were maintained (Fig 5). After 48 h and 72 h, HSF-
*
214 Med Arh. 2015 Aug; 69(4): 212-217
In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
**
* *
Fibroblast migration and proliferation (mm)
*
Fig3. Proliferation and cell migration in scratch wound invasion assay after 1day (24h) of conditioned
media treatment. Significantly increased (*p<0.05) proliferation and cellular viability was observed in
HSF-PI-16 treated with HEAML media versus respective control media after 24 h. As shown, there
was a significant increase in HSF-PI-16 cell number in RPMI + %10 FBS culture media after 24 h,
which was beyond the time course for wound closure by HSF-PI-16 cell type in the presence of
HEAML
Figure 3. Proliferation and cell migration in scratch wound invasion assay a er 1day (24h) of conditioned media treatment. Signicantly increased (*p<0.05) proliferation and cellular viability was observed in HSF-PI-16 treated with HEAML media versus respective control media a er 24 h. As shown, there was a signicant increase in HSF-PI-16 cell number in RPMI + %10 FBS culture media a er 24h, which was beyond the time course for wound closure by HSF-PI-16 cell type in the presence of HEAML
*
Fibroblast migration and proliferation (mm)
PI-16 media elicited consistently higher proliferation than media controls. Nevertheless, this dierence was statistically signicant. Similar trends were observed in human skin broblasts. RPMI + %10 FBS cultures of HSF-PI-16 showed statistically (p<0.05) elevated proliferation when treated with IC50 media versus corresponding HSF-PI-16 control media (Table 1). Overall proliferation rates were greater, and statistically signicant, in HEAML versus the corresponding HSF-PI-16 cells media regimens. As cell
proliferation, growth factor production and cell contrac-tile capacity were promoted by HEAML, we hypothesized that HEAML could promote cell growth and that this stimulatory eect could be transmitted from one cell generation to another. To address this possibility, broblasts were exposed to HEAML and subsequently cultured for 24 h. Th ey were then trypsinized and subcultured for 24, 48, and 72 h to measure cell growth.
3.3. Evaluation of HSF-PI-16 index by inverted microscope
Cell index (CI) measured by the label free inverted microscope system is used as a guide to monitor cellular behavior including spreading, proliferation, viability and morphology (Table 1) (Figures 1 and 2). Dynamic responses in our panel of cells (to dierent conditioned media) were continuously monitored following 24 h cell synchronization. HSF-PI-16 cells treated with HEAML conditioned media produced steady increases in CI from 2472 h, indicating an enhanced HSF-PI-16 cell spread-
ing, proliferation and changes in cellular morphology .Th e highest overall CI was from HSF-PI-16 followed by HEAML media treatments in which treated media elicited consistently higher CI for the duration of 72 h. Th e addition of HEAML in the culture medium did inuence the wound closure and therefore had signicant eect on the migratory capacity of broblasts in culture. However, a slight increase, approximately 2.4% of the wound closure, was observed in the presence of HEAML (25mg/ml) after 72 h of incubation, and this increase was signicant (Figure 5). We also observed that the broblasts cultured with the HEAML at RPMI + %10 FBS media had a higher density than those cultured alone. On day 3 after the cultures were started, the broblasts overgrew and formed several layers of cells when grown alone. To warp up, to understand the long-term eects of IC50 or HEAML and culture on the proliferation of broblasts, some cultures were observed on the 1, 2, and 3 day after the cultures were initiated. As shown in Figure 5, the broblasts in the
*
*
Fig5. Proliferation and cell migration in scratch wound invasion assay after 3day (72h) of conditioned media treatment. Significantly increased (*p<0.05) proliferation and cellular viability was observed in HSF-PI-16 treated with HEAML media versus respective control media after 72 h. As shown, there was a significant increase in HSF-PI-16 cell number in RPMI + %10 FBS culture media after 72 h, which was beyond the time course for wound closure by HSF-PI-16 cell type in the presence of HEAML
**
*
Figure 5. Proliferation and cell migration in scratch wound invasion assay a er 3day (72h) of conditioned media treatment. Signicantly increased (*p<0.05) proliferation and cellular viability was observed in HSF-PI-16 treated with HEAML media versus respective control media a er 72 h. As shown, there was a signicant increase in HSF-PI-16 cell number in RPMI + %10 FBS culture media a er 72h, which was beyond the time course for wound closure by HSF-PI-16 cell type in the presence of HEAML
Fibroblast migration and proliferation (mm)
*
Fig4. Proliferation and cell migration in scratch wound invasion assay after 2day (48h) of conditioned
media treatment. Significantly increased (*p<0.05) proliferation and cellular viability was observed in
HSF-PI-16 treated with HEAML media versus respective control media after 48 h. As shown, there
was a significant increase in HSF-PI-16 cell number in RPMI + %10 FBS culture media after 48 h,
which was beyond the time course for wound closure by HSF-PI-16 cell type in the presence of
HEAML
Figure 4. Proliferation and cell migration in scratch wound invasion assay a er 2day (48h) of conditioned media treatment. Signicantly increased (*p<0.05) proliferation and cellular viability was observed in HSF-PI-16 treated with HEAML media versus respective control media a er 48 h. As shown, there was a signicant increase in HSF-PI-16 cell number in RPMI + %10 FBS culture media a er 48h, which was beyond the time course for wound closure by HSF-PI-16 cell type in the presence of HEAML
Med Arh. 2015 Aug; 69(4): 212-217
215
In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
co-culture with additional IC50 maintained fast proliferation after day 3, while those in other cultures grew much slower. The broblasts in the control group exhibited a marked reduction in the proliferation rate following day 3. Since the broblasts in the culture with HEAML did not exhibit a reduction in the proliferation rate, the faster broblasts proliferation in the treat group during the late stage of the co-culture could be caused by an insufficient level of basic nutrition in media.
4. DISCUSSION
This is the rst published in vitro study demonstrating the eects of HEAML on broblasts proliferation obtained from dierent anatomical cultures. It is also the rst study to compare such eects against the long-standing commercially available controlled. In this study, we used an in vitro scratch wound healing model and were able to assess the eects of HEAML compared to control on cultured broblasts. Application of A. millefolium stimulates cellular spreading, attachment and proliferation in a dose-dependent and time-dependent manner at the cellular level and also shows dose-dependent stimulation at the transcriptional level for many ECM components such as HSF and its growth factors.
Our ndings allowed highlighting of an increase in the anabolic pathway of ECM, in particular through stimulation of HSF-PI-16 syntheses. However, it is important to note that our results also indicated an increase in the activity and expression of HSF in the presence of A. millefolium extracts. The increased expression in the ECM levels of HSF-PI-16 is correlated to the enhancement of broblast cells activity after 48 h and 72 h incubation in the presence of HEAML, and its stimulation should lead to an increase in the amount of ECM components such as HSF. Moreover, our results revealed that A. millefolium extract stimulated expression in the HSF-PI-16 levels of ECM. This HEAML is a transcriptional stimulator of ECM genes like those encoding type broblast cells activity and is largely responsible for the increase in the expression of broblast synthesis occurring during aging of the dermal broblasts (23, 24). Indeed, even if our extracts increased the synthesis of HSF-PI-16 in vitro, they also stimulated the synthesis of broblasts. It appears that the anabolic/catabolic balance could be in favor of matrix material synthesis despite HSF-PI-16 activity stimulation. On the other hand, our extracts increased the mRNA levels of HSF.
Cell proliferation and migration are hallmarks of cell division. DNA duplication is the key step in cell division and it is controlled by dierent stages: G1/0, G2/M, and S phases of cell cycle (25). Fibroblast cell proliferation and migration phenomena are principally governed by Rho family GTPase like Rac-1, Rho-A, and Cdc-42 (26). The cell cycle phases are coordinated by the expression and/ or activation of regulatory proteins, like cyclins (e.g., cyclin A, D, and E), cyclin-dependent kinases (Cdk) mainly Cdk-1 and -2, and Cdk inhibitors. Both cyclins and cyclin-dependent kinases have also been implicated in the formation of actin ytoskeleton in mammalian broblast cells (27). These cells, key players in the wound healing process, are responsible for cell-mediated matrix con-
traction (28, 29). Through a contraction of their actin cytoskeleton, myobroblasts at the wound site are able to reduce the initial size of the wound, thereby contributing to tissue repair.
A dose-dependent increase in cell number was noticed during 48 h treatment period with maximum and significant (p<0.05) increase at 25 mg/mL concentration level, therefore, high concentration of HEAML (25 mg/mL) stimulated cell proliferation and displayed non-cytotoxic eect on HSF-PI-16 cells. Treatment with mentioned dose of HEAML exhibited over 35% increase in cell number at 48 h. However, at other concentration, there was dierence in cell proliferation between the control groups cells and cells treated with HEAML. This study supports several other investigations that reported that natural antioxidants increased the number of oral broblast (30) and endothelial cells (31) and modulated the growth of endometrial stromal cells (32). Functional end point of bro-blast cell division and proliferation is cell migration (33) into wounded area (30). An established in vitro scratch assay model was used to quantitatively dene human skin broblast migration in a monolayer cell model by using invert microscope Image J software analysis, as Figure 2 shown, HEAML dose dependently increased the rate of migration into chamber wounded area up to the concentration of 3.12 to 25 mg/mL. The rate of cell migration was similar to that observed in the presence of A. millefolium leaves, a potent cell migration inducer. Therefore it is proposed that HEAML is non-cytotoxic with proproliferative capacity to induce broblast cell migration, which these processes cultured at a RPMI + %10 FBS media involved with bovine serum for growth. In parallel, a recent study by Smith et al. (34) reported that culture of murine MSC with HSF, where each cell type was separated in a modied Boyden chamber in the presence of bovine and equine serum, enhanced dermal broblast migration and proliferation. The response of the dermal broblasts included altered expression of genes involved in cell-matrix interactions. Therefore ,this suggests that increased migration of these cells at a FBS media , as stimulated to increased proliferation, was the main factor in the enhanced rate of scratch wound closure in each chamber of HSF.
We routinely observed a higher proportion of broblasts with small to large size cells and low granularity in control samples. HSF-PI-16 are for long known to produce clones with heterogeneous characteristics in low density cultures (35, 36). In this context, it is interesting to note that, in long-term cultures of broblasts used as an in vitro model of cell aging, an increase of the growth potential (37, 38), an increased number of HSF cells (39), and an increased protein production (40), have been reported, which is in agreement with our results. In agreement with mentioned studies, our study showed that constant HEAML at 3.12 to 25 mg/mL at 48 and 72h mediated by promoted skin broblast growth, enhanced cell migration, and increased related growth factors production. It is also indicated that such modied cellular behaviors were inherited by the cells up to 2 to 3 days in culture.
Our overall ndings thus suggest the benecial eect of HEAML on wound healing processes. On the other hand, The HEAML-enhanced broblast migration and extra-
216 Med Arh. 2015 Aug; 69(4): 212-217
In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16)
cellular matrix contraction observed in our study can be explained by the high expression of HSF-PI-16 by the skin broblasts following exposure to HEAML at 6.25 and 25 mg/ml. It is important to note the potential dose eect of IC50, as the highest level of HSF-PI-16 expression was obtained at the highest HEAML intensity (25mg/ml) and for the longest exposure period (48and 72 h exposure to IC50).
5. CONCLUSION
We have adapted an established in vitro model of skin wound healing; this was with a view to investigating the potential use of HEAML for HSF-PI-16 therapies of cutaneous wounds. The study has demonstrated that HSF-PI-16 brings about wound closure in scratch assays under serum and serum free conditions, where HSF-PI-16 pioneered the wound healing process. These studies provide a novel model system for the in vitro study of cell synthesized soluble factors that may inuence skin wound healing and provide insight into the potential mechanisms whereby HEAML transplantation is therapeutic. To warp up, the reaction of in vitro broblasts plays a signicant role in the healing process. Hence, the incorporation of HSF in this culture model may be more representative of in vivo skin wound healing for the use of this cell type. Moreover,this study clearly demonstrates that HEAML had no cytotoxic eect on human skin broblasts seeded on HSF-PI-16 conductive FBS cultures. The broblasts non-adhered well and proliferated exponentially following various exposure periods to IC50. Although cells were found to adhere to both the HEAML -exposed and non-exposed FBS cultures, the HEAML -exposed cultures produced a higher number of viable cells and comparable control groups activity, and/ or compared to the non-exposed Medias. Of particular interest is that cell viability/density increased with longer exposure periods (48 and 77 h).
CONFLICT OF INTEREST: NONE DECLARED.
REFERENCES
1. De Smet PA. Health risks of herbal remedies: an update. Clin Pharmacol Ther. 2004 ; 76(1): 1-17.
2. Nemeth E, Bernath J. Biological activities of yarrow species (Achillea spp.). Curr Pharm Des. 2008; 14(29): 3151-3167.
3. Schultz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physicians Guide to Herbal Medicine, Springer, Berlin, 2001: 294.
4. Benedek B, Kopp B. Achillea millefolium L. s.l. revisited: recent ndings conrm the traditional use. Wien Med Wochenschr. 2007; 157(13-14): 312-314.
5. Fetrow CW, Avila JR. Professionals Handbook of Complementary and Alternative Medicines, third ed. Lippincott, Williams, & Wilkins, Philadelphia. 2004.
6. Johannsdottir AL. Icelandic Medicinal Plants: Collection, Usage and Effects (In Icelandic), second ed. Mal og menning, Reykjavik,2009.
7. Liu C, Zhao Y, Wang Y. Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug. Appl Microbiol Biotechnol. 2006; 72(1): 11-20.
8. Mastromonaco GF, Perrault SD, Betts DH, King WA. Role of chromo-some stability and telomere length in the production of viable cell lines for somatic cell nuclear transfer. BMC Dev Biol. 2006; 6: 41-53.
9. Jongkind JF, Verkerk A .Cell sorting and microchemistry of cultured human broblasts: applications in genetics and aging research. Cytometry. 1984; 5: 182-187.
10. Wong T, McGrath JA, Navsaria H. The role of broblasts in tissue engineering and regeneration. Br J Dermatol. 2007; 156: 1149-1155.
11. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009; 37(5): 1528-1542.
12. Rehman S, Goodacre R, Day PJ, Bayat A, Westerho HV .Dupuytrens: a systems biology disease. Arthritis Res Ther. 2011; 13: 238.
13. Eyden B. The myobroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med. 2008; 12: 22-37.
14. Huang C, Ogawa R. Fibroproliferative disorders and their mechanobiology. Connect Tissue Res 2012; 53: 187-196.
15. Saika S, Yamanaka O, Okada Y, Tanaka S, Miyamoto T, Sumioka T. TGF beta in broproliferative diseases in the eye. Front Biosci (Schol Ed). 2009;1: 376-390.
16. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmouliere A .Mechanisms of pathological scarring: role of myobroblasts and current developments. Wound Repair Regen. 2011; 19(Suppl 1): s10-15.
17. Singh M, Foster CR, Dalal S, Singh K .Role of osteopontin in heart failure associated with aging. Heart Fail Rev. 2010; 15: 487-494.
18. Wynn TA. Integrating mechanisms of pulmonarybrosis. J Exp Med.
2011; 208: 1339-1350.
19. Goli SAH, Rahim Mailk M, Sayed Tabatabaei BE. Physicochemical characteristics and fatty acid prole of yarrow (achillea tenuifolia) seed oil. Int J Agr Biol. 2008; 10: 355-357.
20. Moradkhani Sh, Ayatollahi AM, Ghanadian M, Moind MR, Razavizadehe M. Phytochemical analysis and metal-chelation activity of achillea tenuifolia Lam. Iran. J Pharm Res. 2012; 11:177-183.
21. De Souza P, Gasparotto A Jr, Crestani S, Stefanello M, Marques MC, da Silva-Santos JE, Kassuya CA.Hypotensive mechanism of the extracts and artemetin isolated from Achillea millefolium L. (Asteraceae) in rats. Phytomedicine. 2011; 15; 18(10): 819-825.
22. Syed F, Thomas AN, Singh S, Kolluru V, Emeigh Hart SG, Bayat A. In vitro study of novel collagenase (XIAFLEX) on Dupuytrens disease broblasts displays unique drug related properties. PLoS One. 2012; 7(2): e31430.
23. Beauchef G, Bigot N, Kypriotou M, Renard E, Pore B. The p65 subunit of NF-B inhibits COL1A1 gene transcription in human dermal and scleroderma broblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3). J Biol Chem. 2012; 287: 34623478.
24. Bigot N, Beauchef G, Hervieu M, Oddos T, Demoor M. NF-B accumulation associated with COL1A1 transactivators defects during chronological aging represses type I collagen expression through a 112/61 bp region of the COL1A1 promoter in human skin broblasts. J Invest Dermatol. 2012; 132: 23602367. doi: 10.1038/jid.2012.164
25. Almonacid M, Paoletti A. Mechanisms controlling division-plane positioning. Semin Cell Dev Biol. 2010; 21(9): 874-880.
26. DSouza KM, Malhotra R, Philip JL, Staron ML, Theccanat T.G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac broblasts. J Biol Chem. 2011; 29; 286(17): 15507-16.
27. Yoshizaki H, Ohba Y, Parrini MC, Dulyaninova NG, Bresnick AR. Cell type-specic regulation of RhoA activity during cytokinesis. J Biol Chem. 2004; 279(43): 44756-62.
28. Follonier CL, Gabbiani G, McCulloch CA, Hinz B . Regulation of myobroblast activities: calcium pulls some strings behind the scene. Exp Cell Res. 2010; 316: 2390-2401.
29. Dabiri G, Tumbarello DA, Turner CE, Van de Water L . Hic-5 promotes the hypertrophic scar myobroblast phenotype by regulating the TGF-beta1 autocrine loop. J Invest Dermatol. 2008; 128: 2518-2525.
30. San Miguel SM, Opperman LA, Allen EP, Zielinski J, Svoboda KK.Bio-active antioxidant mixtures promote proliferation and migration on human oral broblasts. Arch Oral Biol. 2011; 56(8): 812-822.
31. Fiorito C, Rienzo M, Crimi E, Rossiello R, Balestrieri ML, Casamassimi A. Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res. 2008; 42(8): 754-762.32. Foyouzi N, Berkkanoglu M, Arici A, Kwintkiewicz J, Izquierdo D, Duleba AJ. Eects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril. 2004 ; 82 Suppl 3: 1019-1022.
33. Novk B, Vinod PK, Freire P, Kapuy O.Systems-level feedback in cell-cycle control. Biochem Soc Trans. 2010; 38(5): 1242-1246.
34. Smith AN, Willis E, Chan VT, Muffley LA, Isik FF. Mesenchymal stem cells induce dermal broblast responses to injury. Exp Cell Res. 2010; 316(1): 48-54.
35. Smith JR, Pereira-Smith OM, Schneider EL . Colony size distributions as a measure of in vivo and in vitro aging. Proc Natl Acad Sci USA. 1978; 75: 1353-1356.
36. Smith JR, Hayick L. Variation in the life span of clones derived from human diploid cell strains. J Cell Biol. 1974; 62: 48-53.
37. Hayick L . The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37: 614636.
38. Hayick L .The cell biology of aging. J Invest Dermatol. 1979; 73: 8-14.39. Angello JC, Pendergrass WR, Norwood TH, Prothero J . Proliferative potential of human broblasts: An inverse dependence on cell size. J Cell Physiol. 1987; 132: 125-130.
40. Cristofalo VJ, Pignolo RJ . Replicative senescence of human broblast-like cells in culture. Physiol Rev. 1993; 73: 617-638.
Med Arh. 2015 Aug; 69(4): 212-217
217
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Academy of Medical Sciences of Bosnia and Herzegovina 2015
Abstract
Aim: In the present study, we aimed the effects of the hydroalcoholic extract of Achillea millefolium (HEAML) on human skin fibroblast cells (HSF-PI-16) proliferation, stimulation and growth properties. Methods: Initially, using HSF-PI-16 monolayer culture, we created one line scratch method as an in vitro wound closure and after 3 days monitored via an inverted microscopy. Results: HEAML selectively inhibited proliferation of HSF-PI-16 cells at higher concentration (>20.0 mg/mL), and stimulated at lower concentrations (<20.0 mg/mL).Following, HSF-PI-16 media treatments up to 72 h, HEAML demonstrated significantly elevated proliferation rates (p<0.05) and stimulation in a scratch wound assay (p<0.04). Furthermore, the morphological analysis of HSF-PI-16 cells at culture media were detected the figures of round to spindle, non-adherent, immature and mature cells. Conclusion: These results clearly demonstrate the absence of any toxic effect of HEAML on human skin fibroblasts. To the best of our knowledge, this is the first report elucidating potential mechanisms of action of HEAML on fibroblasts proliferation, and stimulation, offering a greater insight and a better understanding of its effect in future studies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer